Chemeq says it will meet production requirements

By Melissa Trudinger
Tuesday, 08 March, 2005

Chemeq (ASX:CMQ) has clarified its current and future production capabilities after questions were raised in a research report about the ability of the company to produce the levels of product required by new investment partner Mizuho.

As one of the conditions of the company's AUD$60 million rescue by Mizuho, Chemeq is required to obtain confirmed sales orders for a minimum of 40,000 litres of its polymeric antimicrobial in the 2005-2006 financial year by the end of September this year.

But a recent issue of biotech investor newsletter Bioshares questioned whether the company's production levels were adequate to meet this.

Now the company has confirmed that its current production levels are 60,000-100,000 litres of product, which equates to approximately 15-25 per cent of plant capacity. Ultimately, the plant is expected to reach a production output of 400,000 litres of finished product.

Related News

Vanillin flavouring in vapes may disrupt embryo development

Vanillin — a common flavouring chemical in e-cigarettes — may disrupt the normal...

Heart valve tissues created from stem cells

The breakthrough should help advance our understanding into how human heart valves develop,...

Breast augmentation procedure uses 3D-printed scaffolds

3D-printed scaffold technology from medtech company BellaSeno has been used in a primary breast...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd